This statement seems to be bending over backwards to discounted any adverse effect of an admittedly dangerous compound. How much does our trade policy with China affect the FDA’s public statements, I wonder?
Yes, not only is it bending over backwards to discount any adverse effects, it seems to be also be the polar opposite of their usual policy with regard to drug testing.